Open access · US-GOV
via ClinicalTrials.gov Clinical trial
Metabolic Dysregulation as Biomarker of Frailty: Role of the Mitochondrial Dysfunction
Authors not listed
University Hospital of Ferrara · 2024
Abstract
The goal of this observational study is to evaluate the presence of mitochondrial dysfunction(definition) related to oxidative stress and its possible role in frailty, with and without multimorbidity, and to identify possible frailty biomarkers correlated with mitochondrial dysfunction. The main questions it aims to answer are:
* What is the role of oxidative stress-related mitochondrial dysfunction in frailty, taking into account the interaction with multimorbidity.
* What could be the specific biomarkers associated with mitochondrial dysfunction in the assessment of frailty.
In order to reach the study goals, we will enroll three categories of older adults:
* Non-Frail without Multimorbidity (NFWoM);
* Frail with Multimorbidity (FWM);
* Frail without Multimorbidity (FWoM).
Each individual will undergo an assessment of frailty phenotype and multimorbidity, and the collection of blood samples to isolate Peripheral Blood Mononuclear Cells (PBMCs). The identification of frailty biomarkers in each group of participants will be performed by combining untargeted metabolomics-based approaches and functional studies on specific mitochondrial dysfunctions performed on PBMCs and their subpopulations. Multivariate statistical and machine learning techniques will characterize the three clinical phenotype groups based on molecular data.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-10-28 MST
Cite this
APA
Anonymous. (2024). Metabolic Dysregulation as Biomarker of Frailty: Role of the Mitochondrial Dysfunction. <em>University Hospital of Ferrara</em>. https://clinicaltrials.gov/study/NCT06433427
Vancouver
Anonymous. Metabolic Dysregulation as Biomarker of Frailty: Role of the Mitochondrial Dysfunction. University Hospital of Ferrara. 2024.
BibTeX
@misc{anon2024Metabo,
title = {Metabolic Dysregulation as Biomarker of Frailty: Role of the Mitochondrial Dysfunction},
author = {Anonymous},
journal = {University Hospital of Ferrara},
year = {2024},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
CHU de Reims 2014
Open access · US-GOV
Fragmentation of Elastin as a Biological Marker of Frailty and Impact in Tumor Progression in Elderly Patients With Cancer
AGE 2015
Open access · OA
Biomarkers of oxidative stress are associated with frailty: the Framingham Offspring Study
Mayo Clinic 2023
Open access · US-GOV
The Role of the Comprehensive Geriatric Assessment in Elderly Patients With Multiple Myeloma: A Single Center Prospective Study
Neurochemistry International 2011
Citation only
Mitochondrial dysfunction in brain aging: Role of oxidative stress and cardiolipin
Parc de Salut Mar 2024
Open access · US-GOV
ASSESSMENT OF THE ADEQUACY IN CARE OF THE FRAGILE PATIENT IN A DIGESTIVE ENDOSCOPY UNIT FRIEND Study (FRailty In ENDoscopy) Estudi FRIEND (FRailty In ENDoscopy)
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2013
Open access · OA